Inclusion criteria  Population 1: 'Prevalence of a history of cardiovascular disease (CVD) among persons with type 2 diabetes mellitus (T2DM) who were alive on 31 December 2017' :  Diagnosed with T2DM in Sweden Alive on 31 December 2017 At least one registration in the Swedish National Diabetes Register (NDR) Each patient provides informed consent for inclusion in the register  Population 2: 'Prevalence of a history of CVD among persons with type 2 diabetes who started empagliflozin treatment between 1 January 2015 and 31 December 2017':  Diagnosed with T2DM in Sweden Alive on 31 December 2017 Initiated on empagliflozin between 1 January 2015 and 31 December 2017 At least one registration in the NDR Each patient provides informed consent for inclusion in the register  Exclusion criteria:  none